Vita Life Sciences Ltd - Asset Resilience Ratio

Latest as of June 2025: 39.38%

Vita Life Sciences Ltd (VLS) has an Asset Resilience Ratio of 39.38% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Vita Life Sciences Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$29.40 Million

≈ $20.80 Million USD Cash + Short-term Investments

Total Assets

AU$74.64 Million

≈ $52.82 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Vita Life Sciences Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see VLS asset base.

Liquid Assets Composition Over Time

This chart breaks down Vita Life Sciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Vita Life Sciences Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$29.40 Million	39.38%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$29.40 Million	39.38%

Asset Resilience Insights

Very High Liquidity: Vita Life Sciences Ltd maintains exceptional liquid asset reserves at 39.38% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vita Life Sciences Ltd Industry Peers by Asset Resilience Ratio

Compare Vita Life Sciences Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Vita Life Sciences Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Vita Life Sciences Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	29.90%	AU$21.50 Million ≈ $15.21 Million	AU$71.89 Million ≈ $50.87 Million	-2.21pp
2023-12-31	32.11%	AU$19.20 Million ≈ $13.59 Million	AU$59.81 Million ≈ $42.32 Million	+24.68pp
2022-12-31	7.42%	AU$3.85 Million ≈ $2.72 Million	AU$51.80 Million ≈ $36.65 Million	-5.81pp
2021-12-31	13.23%	AU$5.99 Million ≈ $4.24 Million	AU$45.27 Million ≈ $32.03 Million	+2.03pp
2020-12-31	11.21%	AU$4.38 Million ≈ $3.10 Million	AU$39.10 Million ≈ $27.67 Million	+5.43pp
2019-12-31	5.77%	AU$2.11 Million ≈ $1.49 Million	AU$36.51 Million ≈ $25.84 Million	-24.86pp
2018-12-31	30.63%	AU$10.94 Million ≈ $7.74 Million	AU$35.72 Million ≈ $25.27 Million	+17.52pp
2017-12-31	13.11%	AU$4.32 Million ≈ $3.06 Million	AU$32.95 Million ≈ $23.32 Million	+7.82pp
2016-12-31	5.30%	AU$1.71 Million ≈ $1.21 Million	AU$32.36 Million ≈ $22.90 Million	+0.24pp
2015-12-31	5.05%	AU$1.64 Million ≈ $1.16 Million	AU$32.39 Million ≈ $22.92 Million	--

pp = percentage points

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$107.05 Million

AU$151.30 Million AUD

Market Cap Rank

#19041 Global

#605 in Australia

Share Price

AU$2.77

Change (1 day)

+2.21%

52-Week Range

AU$2.27 - AU$2.83

All Time High

AU$2.83